174 related articles for article (PubMed ID: 31213659)
1. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.
Qian F; Rookus MA; Leslie G; Risch HA; Greene MH; Aalfs CM; Adank MA; Adlard J; Agnarsson BA; Ahmed M; Aittomäki K; Andrulis IL; Arnold N; Arun BK; Ausems MGEM; Azzollini J; Barrowdale D; Barwell J; Benitez J; Białkowska K; Bonadona V; Borde J; Borg A; Bradbury AR; Brunet J; Buys SS; Caldés T; Caligo MA; Campbell I; Carter J; Chiquette J; Chung WK; Claes KBM; Collée JM; Collonge-Rame MA; Couch FJ; Daly MB; Delnatte C; Diez O; Domchek SM; Dorfling CM; Eason J; Easton DF; Eeles R; Engel C; Evans DG; Faivre L; Feliubadaló L; Foretova L; Friedman E; Frost D; Ganz PA; Garber J; Garcia-Barberan V; Gehrig A; Glendon G; Godwin AK; Gómez Garcia EB; Hamann U; Hauke J; Hopper JL; Hulick PJ; Imyanitov EN; Isaacs C; Izatt L; Jakubowska A; Janavicius R; John EM; Karlan BY; Kets CM; Laitman Y; Lázaro C; Leroux D; Lester J; Lesueur F; Loud JT; Lubiński J; Łukomska A; McGuffog L; Mebirouk N; Meijers-Heijboer HEJ; Meindl A; Miller A; Montagna M; Mooij TM; Mouret-Fourme E; Nathanson KL; Nehoray B; Neuhausen SL; Nevanlinna H; Nielsen FC; Offit K; Olah E; Ong KR; Oosterwijk JC; Ottini L; Parsons MT; Peterlongo P; Pfeiler G; Pradhan N; Radice P; Ramus SJ; Rantala J; Rennert G; Robson M; Rodriguez GC; Salani R; Scheuner MT; Schmutzler RK; Shah PD; Side LE; Simard J; Singer CF; Steinemann D; Stoppa-Lyonnet D; Tan YY; Teixeira MR; Terry MB; Thomassen M; Tischkowitz M; Tognazzo S; Toland AE; Tung N; van Asperen CJ; van Engelen K; van Rensburg EJ; Venat-Bouvet L; Vierstraete J; Wagner G; Walker L; Weitzel JN; Yannoukakos D; ; ; ; ; Antoniou AC; Goldgar DE; Olopade OI; Chenevix-Trench G; Rebbeck TR; Huo D;
Br J Cancer; 2019 Jul; 121(2):180-192. PubMed ID: 31213659
[TBL] [Abstract][Full Text] [Related]
2. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.
Qian F; Wang S; Mitchell J; McGuffog L; Barrowdale D; Leslie G; Oosterwijk JC; Chung WK; Evans DG; Engel C; Kast K; Aalfs CM; Adank MA; Adlard J; Agnarsson BA; Aittomäki K; Alducci E; Andrulis IL; Arun BK; Ausems MGEM; Azzollini J; Barouk-Simonet E; Barwell J; Belotti M; Benitez J; Berger A; Borg A; Bradbury AR; Brunet J; Buys SS; Caldes T; Caligo MA; Campbell I; Caputo SM; Chiquette J; Claes KBM; Margriet Collée J; Couch FJ; Coupier I; Daly MB; Davidson R; Diez O; Domchek SM; Donaldson A; Dorfling CM; Eeles R; Feliubadaló L; Foretova L; Fowler J; Friedman E; Frost D; Ganz PA; Garber J; Garcia-Barberan V; Glendon G; Godwin AK; Gómez Garcia EB; Gronwald J; Hahnen E; Hamann U; Henderson A; Hendricks CB; Hopper JL; Hulick PJ; Imyanitov EN; Isaacs C; Izatt L; Izquierdo Á; Jakubowska A; Kaczmarek K; Kang E; Karlan BY; Kets CM; Kim SW; Kim Z; Kwong A; Laitman Y; Lasset C; Hyuk Lee M; Won Lee J; Lee J; Lester J; Lesueur F; Loud JT; Lubinski J; Mebirouk N; Meijers-Heijboer HEJ; Meindl A; Miller A; Montagna M; Mooij TM; Morrison PJ; Mouret-Fourme E; Nathanson KL; Neuhausen SL; Nevanlinna H; Niederacher D; Nielsen FC; Nussbaum RL; Offit K; Olah E; Ong KR; Ottini L; Park SK; Peterlongo P; Pfeiler G; Phelan CM; Poppe B; Pradhan N; Radice P; Ramus SJ; Rantala J; Robson M; Rodriguez GC; Schmutzler RK; Hutten Selkirk CG; Shah PD; Simard J; Singer CF; Sokolowska J; Stoppa-Lyonnet D; Sutter C; Yen Tan Y; Teixeira RM; Teo SH; Terry MB; Thomassen M; Tischkowitz M; Toland AE; Tucker KM; Tung N; van Asperen CJ; van Engelen K; van Rensburg EJ; Wang-Gohrke S; Wappenschmidt B; Weitzel JN; Yannoukakos D; ; ; ; Greene MH; Rookus MA; Easton DF; Chenevix-Trench G; Antoniou AC; Goldgar DE; Olopade OI; Rebbeck TR; Huo D
J Natl Cancer Inst; 2019 Apr; 111(4):350-364. PubMed ID: 30312457
[TBL] [Abstract][Full Text] [Related]
3. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
Kast K; John EM; Hopper JL; Andrieu N; Noguès C; Mouret-Fourme E; Lasset C; Fricker JP; Berthet P; Mari V; Salle L; Schmidt MK; Ausems MGEM; Garcia EBG; van de Beek I; Wevers MR; Evans DG; Tischkowitz M; Lalloo F; Cook J; Izatt L; Tripathi V; Snape K; Musgrave H; Sharif S; Murray J; ; Colonna SV; Andrulis IL; Daly MB; Southey MC; de la Hoya M; Osorio A; Foretova L; Berkova D; Gerdes AM; Olah E; Jakubowska A; Singer CF; Tan Y; Augustinsson A; Rantala J; Simard J; Schmutzler RK; Milne RL; Phillips KA; Terry MB; Goldgar D; van Leeuwen FE; Mooij TM; Antoniou AC; Easton DF; Rookus MA; Engel C
Breast Cancer Res; 2023 Jun; 25(1):72. PubMed ID: 37340476
[TBL] [Abstract][Full Text] [Related]
4. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Milne RL; Osorio A; Ramón y Cajal T; Baiget M; Lasa A; Diaz-Rubio E; de la Hoya M; Caldés T; Teulé A; Lázaro C; Blanco I; Balmaña J; Sánchez-Ollé G; Vega A; Blanco A; Chirivella I; Esteban Cardeñosa E; Durán M; Velasco E; Martínez de Dueñas E; Tejada MI; Miramar MD; Calvo MT; Guillén-Ponce C; Salazar R; San Román C; Urioste M; Benítez J
Breast Cancer Res Treat; 2010 Jan; 119(1):221-32. PubMed ID: 19370414
[TBL] [Abstract][Full Text] [Related]
5. Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer.
Yarmolinsky J; Bull CJ; Vincent EE; Robinson J; Walther A; Smith GD; Lewis SJ; Relton CL; Martin RM
JAMA; 2020 Feb; 323(7):646-655. PubMed ID: 32068819
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
Ramus SJ; Kartsonaki C; Gayther SA; Pharoah PD; Sinilnikova OM; Beesley J; Chen X; McGuffog L; Healey S; Couch FJ; Wang X; Fredericksen Z; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Allavena A; Ottini L; Papi L; Gismondi V; Capra F; Radice P; Greene MH; Mai PL; Andrulis IL; Glendon G; Ozcelik H; ; Thomassen M; Gerdes AM; Kruse TA; Cruger D; Jensen UB; Caligo MA; Olsson H; Kristoffersson U; Lindblom A; Arver B; Karlsson P; Stenmark Askmalm M; Borg A; Neuhausen SL; Ding YC; Nathanson KL; Domchek SM; Jakubowska A; Lubiński J; Huzarski T; Byrski T; Gronwald J; Górski B; Cybulski C; Dębniak T; Osorio A; Durán M; Tejada MI; Benítez J; Hamann U; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Bodmer D; Ausems MG; van Os TA; Asperen CJ; Blok MJ; Meijers-Heijboer HE; ; ; Peock S; Cook M; Oliver C; Frost D; Dunning AM; Evans DG; Eeles R; Pichert G; Cole T; Hodgson S; Brewer C; Morrison PJ; Porteous M; Kennedy MJ; Rogers MT; Side LE; Donaldson A; Gregory H; Godwin A; Stoppa-Lyonnet D; Moncoutier V; Castera L; Mazoyer S; Barjhoux L; Bonadona V; Leroux D; Faivre L; Lidereau R; Nogues C; Bignon YJ; Prieur F; Collonge-Rame MA; Venat-Bouvet L; Fert-Ferrer S; ; Miron A; Buys SS; Hopper JL; Daly MB; John EM; Terry MB; Goldgar D; ; Hansen Tv; Jønson L; Ejlertsen B; Agnarsson BA; Offit K; Kirchhoff T; Vijai J; Dutra-Clarke AV; Przybylo JA; Montagna M; Casella C; Imyanitov EN; Janavicius R; Blanco I; Lázaro C; Moysich KB; Karlan BY; Gross J; Beattie MS; Schmutzler R; Wappenschmidt B; Meindl A; Ruehl I; Fiebig B; Sutter C; Arnold N; Deissler H; Varon-Mateeva R; Kast K; Niederacher D; Gadzicki D; Caldes T; de la Hoya M; Nevanlinna H; Aittomäki K; Simard J; Soucy P; ; Spurdle AB; Holland H; Chenevix-Trench G; Easton DF; Antoniou AC;
J Natl Cancer Inst; 2011 Jan; 103(2):105-16. PubMed ID: 21169536
[TBL] [Abstract][Full Text] [Related]
7. Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers.
McGee J; Kotsopoulos J; Lubinski J; Lynch HT; Rosen B; Tung N; Kim-Sing C; Karlan B; Foulkes WD; Ainsworth P; Ghadirian P; Senter L; Eisen A; Sun P; Narod SA;
Obesity (Silver Spring); 2012 Jun; 20(6):1288-92. PubMed ID: 22262156
[TBL] [Abstract][Full Text] [Related]
8. The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers.
Jakubowska A; Rozkrut D; Antoniou A; Hamann U; Lubinski J
Breast Cancer Res Treat; 2010 Jun; 121(3):639-49. PubMed ID: 19876733
[TBL] [Abstract][Full Text] [Related]
9. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
10. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.
Ding YC; McGuffog L; Healey S; Friedman E; Laitman Y; Paluch-Shimon S; Kaufman B; ; Liljegren A; Lindblom A; Olsson H; Kristoffersson U; Stenmark-Askmalm M; Melin B; Domchek SM; Nathanson KL; Rebbeck TR; Jakubowska A; Lubinski J; Jaworska K; Durda K; Gronwald J; Huzarski T; Cybulski C; Byrski T; Osorio A; Cajal TR; Stavropoulou AV; Benítez J; Hamann U; ; Rookus M; Aalfs CM; de Lange JL; Meijers-Heijboer HE; Oosterwijk JC; van Asperen CJ; Gómez García EB; Hoogerbrugge N; Jager A; van der Luijt RB; ; Easton DF; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Lalloo F; Izatt L; Eeles R; Adlard J; Davidson R; Eccles D; Cole T; Cook J; Brewer C; Tischkowitz M; Godwin AK; Pathak H; ; Stoppa-Lyonnet D; Sinilnikova OM; Mazoyer S; Barjhoux L; Léoné M; Gauthier-Villars M; Caux-Moncoutier V; de Pauw A; Hardouin A; Berthet P; Dreyfus H; Ferrer SF; Collonge-Rame MA; Sokolowska J; Buys S; Daly M; Miron A; Terry MB; Chung W; John EM; Southey M; Goldgar D; Singer CF; Tea MK; Gschwantler-Kaulich D; Fink-Retter A; Hansen TV; Ejlertsen B; Johannsson OT; Offit K; Sarrel K; Gaudet MM; Vijai J; Robson M; Piedmonte MR; Andrews L; Cohn D; DeMars LR; DiSilvestro P; Rodriguez G; Toland AE; Montagna M; Agata S; Imyanitov E; Isaacs C; Janavicius R; Lazaro C; Blanco I; Ramus SJ; Sucheston L; Karlan BY; Gross J; Ganz PA; Beattie MS; Schmutzler RK; Wappenschmidt B; Meindl A; Arnold N; Niederacher D; Preisler-Adams S; Gadzicki D; Varon-Mateeva R; Deissler H; Gehrig A; Sutter C; Kast K; Nevanlinna H; Aittomäki K; Simard J; ; Spurdle AB; Beesley J; Chen X; Tomlinson GE; Weitzel J; Garber JE; Olopade OI; Rubinstein WS; Tung N; Blum JL; Narod SA; Brummel S; Gillen DL; Lindor N; Fredericksen Z; Pankratz VS; Couch FJ; Radice P; Peterlongo P; Greene MH; Loud JT; Mai PL; Andrulis IL; Glendon G; Ozcelik H; ; Gerdes AM; Thomassen M; Jensen UB; Skytte AB; Caligo MA; Lee A; Chenevix-Trench G; Antoniou AC; Neuhausen SL;
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1362-70. PubMed ID: 22729394
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
Kuchenbaecker KB; McGuffog L; Barrowdale D; Lee A; Soucy P; Dennis J; Domchek SM; Robson M; Spurdle AB; Ramus SJ; Mavaddat N; Terry MB; Neuhausen SL; Schmutzler RK; Simard J; Pharoah PDP; Offit K; Couch FJ; Chenevix-Trench G; Easton DF; Antoniou AC
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376175
[TBL] [Abstract][Full Text] [Related]
12. Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Engel C; Versmold B; Wappenschmidt B; Simard J; Easton DF; Peock S; Cook M; Oliver C; Frost D; Mayes R; Evans DG; Eeles R; Paterson J; Brewer C; ; McGuffog L; Antoniou AC; Stoppa-Lyonnet D; Sinilnikova OM; Barjhoux L; Frenay M; Michel C; Leroux D; Dreyfus H; Toulas C; Gladieff L; Uhrhammer N; Bignon YJ; Meindl A; Arnold N; Varon-Mateeva R; Niederacher D; Preisler-Adams S; Kast K; Deissler H; Sutter C; Gadzicki D; Chenevix-Trench G; Spurdle AB; Chen X; Beesley J; ; Olsson H; Kristoffersson U; Ehrencrona H; Liljegren A; ; van der Luijt RB; van Os TA; van Leeuwen FE; ; Domchek SM; Rebbeck TR; Nathanson KL; Osorio A; Ramón y Cajal T; Konstantopoulou I; Benítez J; Friedman E; Kaufman B; Laitman Y; Mai PL; Greene MH; Nevanlinna H; Aittomäki K; Szabo CI; Caldes T; Couch FJ; Andrulis IL; Godwin AK; Hamann U; Schmutzler RK;
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2859-68. PubMed ID: 20978178
[TBL] [Abstract][Full Text] [Related]
13. Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.
Jakubowska A; Rozkrut D; Antoniou A; Hamann U; Scott RJ; McGuffog L; Healy S; Sinilnikova OM; Rennert G; Lejbkowicz F; Flugelman A; Andrulis IL; Glendon G; Ozcelik H; ; Thomassen M; Paligo M; Aretini P; ; Kantala J; Aroer B; von Wachenfeldt A; Liljegren A; Loman N; Herbst K; Kristoffersson U; Rosenquist R; Karlsson P; Stenmark-Askmalm M; Melin B; Nathanson KL; Domchek SM; Byrski T; Huzarski T; Gronwald J; Menkiszak J; Cybulski C; Serrano P; Osorio A; Cajal TR; Tsitlaidou M; Benítez J; Gilbert M; ; Rookus M; Aalfs CM; Kluijt I; Boessenkool-Pape JL; Meijers-Heijboer HE; Oosterwijk JC; van Asperen CJ; Blok MJ; Nelen MR; van den Ouweland AM; Seynaeve C; van der Luijt RB; Devilee P; ; Easton DF; Peock S; Frost D; Platte R; Ellis SD; Fineberg E; Evans DG; Lalloo F; Eeles R; Jacobs C; Adlard J; Davidson R; Eccles D; Cole T; Cook J; Godwin A; Bove B; ; Stoppa-Lyonnet D; Caux-Moncoutier V; Belotti M; Tirapo C; Mazoyer S; Barjhoux L; Boutry-Kryza N; Pujol P; Coupier I; Peyrat JP; Vennin P; Muller D; Fricker JP; Venat-Bouvet L; Johannsson OT; Isaacs C; Schmutzler R; Wappenschmidt B; Meindl A; Arnold N; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Preisler-Adams S; Simard J; Soucy P; Durocher F; Chenevix-Trench G; Beesley J; Chen X; ; Rebbeck T; Couch F; Wang X; Lindor N; Fredericksen Z; Pankratz VS; Peterlongo P; Bonanni B; Fortuzzi S; Peissel B; Szabo C; Mai PL; Loud JT; Lubinski J;
Br J Cancer; 2012 Jun; 106(12):2016-24. PubMed ID: 22669161
[TBL] [Abstract][Full Text] [Related]
14. Weight Gain and the Risk of Ovarian Cancer in
Kim SJ; Lubinski J; Huzarski T; Møller P; Armel S; Karlan BY; Senter L; Eisen A; Foulkes WD; Singer CF; Tung N; Bordeleau L; Neuhausen SL; Olopade OI; Eng C; Weitzel JN; Fruscio R; Narod SA; Kotsopoulos J;
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2038-2043. PubMed ID: 34426412
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
Osorio A; Milne RL; Pita G; Peterlongo P; Heikkinen T; Simard J; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; Healey S; ; Neuhausen SL; Ding YC; Couch FJ; Wang X; Lindor N; Manoukian S; Barile M; Viel A; Tizzoni L; Szabo CI; Foretova L; Zikan M; Claes K; Greene MH; Mai P; Rennert G; Lejbkowicz F; Barnett-Griness O; Andrulis IL; Ozcelik H; Weerasooriya N; ; Gerdes AM; Thomassen M; Cruger DG; Caligo MA; Friedman E; Kaufman B; Laitman Y; Cohen S; Kontorovich T; Gershoni-Baruch R; Dagan E; Jernström H; Askmalm MS; Arver B; Malmer B; ; Domchek SM; Nathanson KL; Brunet J; Ramón Y Cajal T; Yannoukakos D; Hamann U; ; Hogervorst FB; Verhoef S; Gómez García EB; Wijnen JT; van den Ouweland A; ; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Luccarini C; Evans DG; Lalloo F; Eeles R; Pichert G; Cook J; Hodgson S; Morrison PJ; Douglas F; Godwin AK; ; Sinilnikova OM; Barjhoux L; Stoppa-Lyonnet D; Moncoutier V; Giraud S; Cassini C; Olivier-Faivre L; Révillion F; Peyrat JP; Muller D; Fricker JP; Lynch HT; John EM; Buys S; Daly M; Hopper JL; Terry MB; Miron A; Yassin Y; Goldgar D; ; Singer CF; Gschwantler-Kaulich D; Pfeiler G; Spiess AC; Hansen TV; Johannsson OT; Kirchhoff T; Offit K; Kosarin K; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov EN; Allavena A; Schmutzler RK; Versmold B; Engel C; Meindl A; Ditsch N; Arnold N; Niederacher D; Deissler H; Fiebig B; Varon-Mateeva R; Schaefer D; Froster UG; Caldes T; de la Hoya M; McGuffog L; Antoniou AC; Nevanlinna H; Radice P; Benítez J;
Br J Cancer; 2009 Dec; 101(12):2048-54. PubMed ID: 19920816
[TBL] [Abstract][Full Text] [Related]
16. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
Eleje GU; Eke AC; Ezebialu IU; Ikechebelu JI; Ugwu EO; Okonkwo OO
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012464. PubMed ID: 30141832
[TBL] [Abstract][Full Text] [Related]
17. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Kuchenbaecker KB; Hopper JL; Barnes DR; Phillips KA; Mooij TM; Roos-Blom MJ; Jervis S; van Leeuwen FE; Milne RL; Andrieu N; Goldgar DE; Terry MB; Rookus MA; Easton DF; Antoniou AC; ; McGuffog L; Evans DG; Barrowdale D; Frost D; Adlard J; Ong KR; Izatt L; Tischkowitz M; Eeles R; Davidson R; Hodgson S; Ellis S; Nogues C; Lasset C; Stoppa-Lyonnet D; Fricker JP; Faivre L; Berthet P; Hooning MJ; van der Kolk LE; Kets CM; Adank MA; John EM; Chung WK; Andrulis IL; Southey M; Daly MB; Buys SS; Osorio A; Engel C; Kast K; Schmutzler RK; Caldes T; Jakubowska A; Simard J; Friedlander ML; McLachlan SA; Machackova E; Foretova L; Tan YY; Singer CF; Olah E; Gerdes AM; Arver B; Olsson H
JAMA; 2017 Jun; 317(23):2402-2416. PubMed ID: 28632866
[TBL] [Abstract][Full Text] [Related]
18. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Couch FJ; Gaudet MM; Antoniou AC; Ramus SJ; Kuchenbaecker KB; Soucy P; Beesley J; Chen X; Wang X; Kirchhoff T; McGuffog L; Barrowdale D; Lee A; Healey S; Sinilnikova OM; Andrulis IL; ; Ozcelik H; Mulligan AM; Thomassen M; Gerdes AM; Jensen UB; Skytte AB; Kruse TA; Caligo MA; von Wachenfeldt A; Barbany-Bustinza G; Loman N; Soller M; Ehrencrona H; Karlsson P; ; Nathanson KL; Rebbeck TR; Domchek SM; Jakubowska A; Lubinski J; Jaworska K; Durda K; Zlowocka E; Huzarski T; Byrski T; Gronwald J; Cybulski C; Górski B; Osorio A; Durán M; Tejada MI; Benitez J; Hamann U; Hogervorst FB; ; van Os TA; van Leeuwen FE; Meijers-Heijboer HE; Wijnen J; Blok MJ; Kets M; Hooning MJ; Oldenburg RA; Ausems MG; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Jacobs C; Eeles RA; Adlard J; Davidson R; Eccles DM; Cole T; Cook J; Paterson J; Brewer C; Douglas F; Hodgson SV; Morrison PJ; Walker L; Porteous ME; Kennedy MJ; Side LE; ; Bove B; Godwin AK; Stoppa-Lyonnet D; ; Fassy-Colcombet M; Castera L; Cornelis F; Mazoyer S; Léoné M; Boutry-Kryza N; Bressac-de Paillerets B; Caron O; Pujol P; Coupier I; Delnatte C; Akloul L; Lynch HT; Snyder CL; Buys SS; Daly MB; Terry M; Chung WK; John EM; Miron A; Southey MC; Hopper JL; Goldgar DE; Singer CF; Rappaport C; Tea MK; Fink-Retter A; Hansen TV; Nielsen FC; Arason A; Vijai J; Shah S; Sarrel K; Robson ME; Piedmonte M; Phillips K; Basil J; Rubinstein WS; Boggess J; Wakeley K; Ewart-Toland A; Montagna M; Agata S; Imyanitov EN; Isaacs C; Janavicius R; Lazaro C; Blanco I; Feliubadalo L; Brunet J; Gayther SA; Pharoah PP; Odunsi KO; Karlan BY; Walsh CS; Olah E; Teo SH; Ganz PA; Beattie MS; van Rensburg EJ; Dorfling CM; Diez O; Kwong A; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Heidemann S; Niederacher D; Preisler-Adams S; Gadzicki D; Varon-Mateeva R; Deissler H; Gehrig A; Sutter C; Kast K; Fiebig B; Heinritz W; Caldes T; de la Hoya M; Muranen TA; Nevanlinna H; Tischkowitz MD; Spurdle AB; Neuhausen SL; Ding YC; Lindor NM; Fredericksen Z; Pankratz VS; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Bernard L; Viel A; Giannini G; Varesco L; Radice P; Greene MH; Mai PL; Easton DF; Chenevix-Trench G; ; Offit K; Simard J;
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):645-57. PubMed ID: 22351618
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.
Rebbeck TR; Kauff ND; Domchek SM
J Natl Cancer Inst; 2009 Jan; 101(2):80-7. PubMed ID: 19141781
[TBL] [Abstract][Full Text] [Related]
20. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Mulligan AM; Couch FJ; Barrowdale D; Domchek SM; Eccles D; Nevanlinna H; Ramus SJ; Robson M; Sherman M; Spurdle AB; Wappenschmidt B; Lee A; McGuffog L; Healey S; Sinilnikova OM; Janavicius R; Hansen Tv; Nielsen FC; Ejlertsen B; Osorio A; Muñoz-Repeto I; Durán M; Godino J; Pertesi M; Benítez J; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Cattaneo E; Bonanni B; Viel A; Pasini B; Papi L; Ottini L; Savarese A; Bernard L; Radice P; Hamann U; Verheus M; Meijers-Heijboer HE; Wijnen J; Gómez García EB; Nelen MR; Kets CM; Seynaeve C; Tilanus-Linthorst MM; van der Luijt RB; van Os T; Rookus M; Frost D; Jones JL; Evans DG; Lalloo F; Eeles R; Izatt L; Adlard J; Davidson R; Cook J; Donaldson A; Dorkins H; Gregory H; Eason J; Houghton C; Barwell J; Side LE; McCann E; Murray A; Peock S; Godwin AK; Schmutzler RK; Rhiem K; Engel C; Meindl A; Ruehl I; Arnold N; Niederacher D; Sutter C; Deissler H; Gadzicki D; Kast K; Preisler-Adams S; Varon-Mateeva R; Schoenbuchner I; Fiebig B; Heinritz W; Schäfer D; Gevensleben H; Caux-Moncoutier V; Fassy-Colcombet M; Cornelis F; Mazoyer S; Léoné M; Boutry-Kryza N; Hardouin A; Berthet P; Muller D; Fricker JP; Mortemousque I; Pujol P; Coupier I; Lebrun M; Kientz C; Longy M; Sevenet N; Stoppa-Lyonnet D; Isaacs C; Caldes T; de la Hoya M; Heikkinen T; Aittomäki K; Blanco I; Lazaro C; Barkardottir RB; Soucy P; Dumont M; Simard J; Montagna M; Tognazzo S; D'Andrea E; Fox S; Yan M; Rebbeck T; Olopade O; Weitzel JN; Lynch HT; Ganz PA; Tomlinson GE; Wang X; Fredericksen Z; Pankratz VS; Lindor NM; Szabo C; Offit K; Sakr R; Gaudet M; Bhatia J; Kauff N; Singer CF; Tea MK; Gschwantler-Kaulich D; Fink-Retter A; Mai PL; Greene MH; Imyanitov E; O'Malley FP; Ozcelik H; Glendon G; Toland AE; Gerdes AM; Thomassen M; Kruse TA; Jensen UB; Skytte AB; Caligo MA; Soller M; Henriksson K; Wachenfeldt vA; Arver B; Stenmark-Askmalm M; Karlsson P; Ding YC; Neuhausen SL; Beattie M; Pharoah PD; Moysich KB; Nathanson KL; Karlan BY; Gross J; John EM; Daly MB; Buys SM; Southey MC; Hopper JL; Terry MB; Chung W; Miron AF; Goldgar D; Chenevix-Trench G; Easton DF; Andrulis IL; Antoniou AC; ; ; ; ; ; ; ;
Breast Cancer Res; 2011; 13(6):R110. PubMed ID: 22053997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
